![Russia Pharmaceutical Industry](https://img.sputnikimages.com/images/vol5%2Fmedia%2Foriginal%2F0000%2F0817%2F04%2F000008170493_0%3A0%3A0%3A0_1400x1000_80_10_1_R3JpZ29yeSBTeXNvZXYgIzgxNzA0OTM%3D_116%3A95_sputnik-8170493-preview_a9afc3a35f14a86040158964906fe25b.jpg)
![Russia Pharmaceutical Industry](https://img.sputnikimages.com/images/vol5%2Fmedia%2Foriginal%2F0000%2F0817%2F04%2F000008170493_0%3A0%3A0%3A0_1400x1000_80_10_1_R3JpZ29yeSBTeXNvZXYgIzgxNzA0OTM%3D_116%3A95_sputnik-8170493-preview_a9afc3a35f14a86040158964906fe25b.jpg)
An employee works at the production site of medicines at the plant of the Amedart company in the Technopolis Moscow Special Economic Zone, in Moscow, Russia.
- Package: Russia Pharmaceutical Industry
- Categories: Economy, Business & Finance, Health
- Location: Moscow, Russia
- Event date: 20.04.2022
- Date published: 20.04.2022
- Author: Grigory Sysoev
- Credit: Sputnik
- Source: Sputnik
- Original: Digital
- Media: JPEG, 8256x5504px, 31.8Mb
- Job-ID: a72b25d4839d516e